Carl Eibl
Managing Director

Current Portfolio Companies:
 
BMS, Inc
Enviance, Inc.
NEXX Systems
NP Photonics, Inc.
Pivotal Systems
ReliOn, Inc.
SpecificMEDIA
Xifin, Inc.

Carl Eibl is a Managing Director at Enterprise Partners. In addition to serving as an investment partner, Carl is also responsible for managing the firm. At Enterprise, Carl leads investments in the technology practice, including web, software and clean-tech based businesses, as well as restructurings and business buyouts and combinations. Carl serves on the boards of numerous current Enterprise portfolio companies - BMS, Enviance, NEXX Systems, NP Photonics, Pivotal Systems, ReliOn,  SpecificMEDIA, and Xifin, Inc.  He also serves on the board of CONNECT and is a former Chairman of The Sanford Burnham Institute for Medical Research.

Prior to joining Enterprise in 2003, Carl was th ...

Administrative Staff Executives

Current Portfolio Companies:
 
BMS, Inc
Enviance, Inc.
NEXX Systems
NP Photonics, Inc.
Pivotal Systems
ReliOn, Inc.
SpecificMEDIA
Xifin, Inc.

Carl Eibl is a Managing Director at Enterprise Partners. In addition to serving as an investment partner, Carl is also responsible for managing the firm. At Enterprise, Carl leads investments in the technology practice, including web, software and clean-tech based businesses, as well as restructurings and business buyouts and combinations. Carl serves on the boards of numerous current Enterprise portfolio companies - BMS, Enviance, NEXX Systems, NP Photonics, Pivotal Systems, ReliOn,  SpecificMEDIA, and Xifin, Inc.  He also serves on the board of CONNECT and is a former Chairman of The Sanford Burnham Institute for Medical Research.

Prior to joining Enterprise in 2003, Carl was the CEO of several high profile technology and life science companies in San Diego. As CEO of publicly-held Maxwell Technologies (MXWL), Carl led the recreation of Maxwell from an engineering and physics service organization for the U.S. military to a high-tech business that develops, manufactures and commercializes energy storage devices called ultracapacitors in the industrial, energy and transportation markets and single board computers and components in the satellite and space market. Before joining Maxwell, Carl served as President of Stratagene Corporation (STGN), then a privately-held biotechnology company selling DNA, RNA, biologicals and laboratory instruments in the pharmaceutical and university biotech research markets.   Stratagene was acquired by Agilent Corporation in 2007 for $250 million.  Carl also served as CEO for Mycogen Corporation a publicly-held agricultural, biotechnology company, which was sold to The Dow Chemical Company at the end of 1998 for $1.1 billion.

Carl holds a J.D. from the Boston University School of Law in Boston, MA, and a B.A. from Cornell University in Ithaca, NY. Carl sits on the board of The Burnham Institute and CONNECT, San Diego’s globally recognized benefits organization fostering entrepreneurship in technology and the life sciences. Carl has been a member of the San Diego Coastal Chapter of the Young Presidents Organization (YPO) for the past 15 years.